ARWR – arrowhead pharmaceuticals, inc. (US:NASDAQ)
Stock Stats
News
Arrowhead Pharmaceuticals Announces Topline Results from Part 2 of Phase 1/2 Study of ARO-C3 in Patients with IgA Nephropathy [Yahoo! Finance]
Arrowhead Pharmaceuticals Announces Topline Results from Part 2 of Phase 1/2 Study of ARO-C3 in Patients with IgA Nephropathy
Arrowhead Pharmaceuticals Showcases Two Clinical-Stage RNAi-Based Candidates to Treat Obesity and Metabolic Diseases
Hypertriglyceridemia Pipeline Market Research 2025: Comprehensive Review on 18+ Companies and 20+ Pipeline Drugs [Yahoo! Finance]
Arrowhead Pharmaceuticals Launches on Rare Disease Day New Patient-Centric Resources for Those Affected by Familial Chylomicronemia Syndrome (FCS) [Yahoo! Finance]
Form 424B7 ARROWHEAD PHARMACEUTICAL
Form 4 ARROWHEAD PHARMACEUTICAL For: Mar 03 Filed by: Anzalone Christopher Richard
Form 144 ARROWHEAD PHARMACEUTICAL Filed by: Anzalone Christopher Richard
Form 144 ARROWHEAD PHARMACEUTICAL Filed by: Anzalone Christopher Richard
Form SCHEDULE 13D ARROWHEAD PHARMACEUTICAL Filed by: Sarepta Therapeutics, Inc.
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.